Sunshine Biopharma Inc.

11/03/2014 | Press release | Archived content

EBOLA VIRUS INFECTIONS COULD POTENTIALLY BE TREATED WITH SUNSHINE BIOPHARMA’S LEAD ANTICANCER COMPOUND, ADVA-27A